CARE Ratings Ltd is Rated Sell

Jan 25 2026 10:10 AM IST
share
Share Via
CARE Ratings Ltd is rated Sell by MarketsMojo. This rating was last updated on 23 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 January 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market standing.
CARE Ratings Ltd is Rated Sell

Current Rating and Its Significance

MarketsMOJO’s current rating of Sell for CARE Ratings Ltd indicates a cautious stance towards the stock. This recommendation suggests that investors should consider reducing their exposure or avoid initiating new positions at present. The rating is derived from a comprehensive evaluation of four key parameters: Quality, Valuation, Financial Trend, and Technicals. Each of these factors contributes to the overall assessment of the stock’s attractiveness and risk profile.

Quality Assessment

As of 25 January 2026, CARE Ratings Ltd holds a good quality grade. This reflects the company’s stable operational performance and consistent profitability. Over the past five years, the company has demonstrated moderate growth, with net sales increasing at an annual rate of 13.14% and operating profit rising by 17.59%. These figures indicate a steady expansion in business activities, albeit not at an aggressive pace. The return on equity (ROE) stands at a healthy 17.7%, signalling efficient utilisation of shareholder capital. This quality grade suggests that the company maintains sound business fundamentals, which is a positive aspect for long-term investors.

Valuation Considerations

Despite the solid quality metrics, the valuation of CARE Ratings Ltd is currently very expensive. The stock trades at a price-to-book (P/B) ratio of 5.4, which is significantly higher than the average valuations observed among its peers in the capital markets sector. This premium valuation implies that the market has priced in high expectations for future growth and profitability. However, such elevated valuations can increase downside risk if the company fails to meet these expectations. The price-earnings-to-growth (PEG) ratio of 0.9 suggests that while the stock’s price growth is somewhat aligned with earnings growth, the premium remains a concern for value-conscious investors.

Financial Trend Analysis

The financial trend for CARE Ratings Ltd is currently positive. The latest data as of 25 January 2026 shows that the company’s profits have increased by 33.7% over the past year, outpacing the stock’s return of 23.67% during the same period. This indicates robust earnings momentum, which is a favourable sign for investors looking for growth potential. However, the company’s long-term growth trajectory is moderate, and the recent profit surge may reflect short-term factors rather than sustained expansion. Investors should weigh this positive trend against the high valuation to assess the risk-reward balance.

Technical Outlook

The technical grade assigned to CARE Ratings Ltd is mildly bearish. Recent price movements show a decline of 1.85% on the day, with a one-week drop of 3.86% and a six-month decrease of 16.28%. These trends suggest some selling pressure and cautious sentiment among traders. The mildly bearish technical stance indicates that the stock may face resistance in the near term, and investors should be vigilant about potential volatility. Technical analysis complements the fundamental view by highlighting market sentiment and price momentum, which are crucial for timing investment decisions.

Stock Performance Overview

As of 25 January 2026, CARE Ratings Ltd has delivered a one-year return of 23.67%, reflecting a reasonable appreciation in share price over the past twelve months. However, shorter-term returns have been less favourable, with declines observed over one day (-1.85%), one week (-3.86%), one month (-2.47%), and three months (-3.37%). The year-to-date return stands at -3.25%, indicating some recent weakness. These mixed performance signals underscore the importance of considering both long-term fundamentals and short-term market dynamics when evaluating the stock.

Implications for Investors

The Sell rating for CARE Ratings Ltd reflects a combination of strong business quality and positive financial trends tempered by expensive valuation and cautious technical signals. For investors, this means that while the company’s underlying operations remain sound, the current market price may not offer an attractive entry point given the premium valuation and recent price weakness. Those holding the stock might consider reassessing their positions, especially if seeking to lock in gains or reduce exposure to potential downside risks. Prospective buyers should carefully evaluate whether the expected growth justifies the high price before committing capital.

Sector and Market Context

CARE Ratings Ltd operates within the capital markets sector, a space often characterised by volatility and sensitivity to economic cycles. The company’s small-cap status adds an additional layer of risk due to typically lower liquidity and higher price fluctuations compared to larger peers. Investors should factor in these sector-specific dynamics alongside the company’s individual metrics when making investment decisions.

Strong fundamentals, solid momentum, fair price – This Large Cap from the NBFC sector checks every box for our Top 1%. This should definitely be on your radar!

  • - Complete fundamentals package
  • - Technical momentum confirmed
  • - Reasonable valuation entry

Add to Your Radar Now →

Summary

In summary, CARE Ratings Ltd’s current Sell rating by MarketsMOJO is grounded in a balanced analysis of its quality, valuation, financial trends, and technical outlook. While the company demonstrates good operational quality and positive earnings growth, the very expensive valuation and mildly bearish technical signals suggest caution. Investors should carefully consider these factors in the context of their portfolio objectives and risk tolerance.

Looking Ahead

Going forward, monitoring the company’s ability to sustain profit growth and any shifts in valuation multiples will be critical. Additionally, changes in market sentiment reflected through technical indicators could provide timely signals for investors to adjust their positions. Staying informed with up-to-date data as of 25 January 2026 and beyond will be essential for making well-informed investment decisions regarding CARE Ratings Ltd.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News